We are live on ! Find out more
NWBOW

Northwest Biotherapeutics, Inc.
NWBOW

Delisted

NWBOW was delisted on the 16th of December, 2016.

Back to rankings

1 hedge funds and large institutions have $180K invested in Northwest Biotherapeutics, Inc. in 2013 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more capital invested

Capital invested by funds: $135K → $180K (+$45K)

50% less funds holding

Funds holding: 2 → 1 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
1
Holders Change
-1
Holders Change %
-50%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

NWBOW Hedge Fund Activity: Q3 2013 in Review

1 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in Northwest Biotherapeutics, Inc. (NWBOW) for Q3 2013, worth a combined $180K — up 33% from $135K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of NWBOW and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

  • 1 institutional investor held Northwest Biotherapeutics, Inc. (NWBOW) as of Q3 2013, down from 2 in Q2 2013.
  • Funds reported $180K of Northwest Biotherapeutics, Inc. stock for Q3 2013, up 33% quarter-over-quarter.
  • 0 funds opened new Northwest Biotherapeutics, Inc. positions in Q3 2013 and 1 closed out, a net change of -1 holder.

Based on aggregated 13F filings for Q3 2013.